PDCD1 and COVID-19: Similar to nonspecific anti-CD3/CD28 stimulation, SARS-CoV-2 S and N proteins may also lead to a state of immune exhaustion in T lymphocytes, with increased CD25 and CD62L and decreased PD-1 and TRAIL in convalescent COVID-19 patients.